AEGiS-Reuters: Mandela Launches S. Africa AIDS Drug Campaign

Reuters, Ltd.Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


Mandela Launches S. Africa AIDS Drug Campaign

Reuters NewMedia - Wednesday, December 04, 2002
Andrew Quinn


JOHANNESBURG, South Africa (Reuters) - Former South African President Nelson Mandela has launched a new drive to bring costly AIDS drugs to his country's poor, saying government inaction and public apathy were sentencing millions to death.

The campaign, organized jointly by the Nelson Mandela Foundation and the South African Medical Association (SAMA), will provide free antiretroviral treatment to 9,000 public sector patients.

"It is a threat to everything and to everybody," Mandela said at Tuesday evening's launch. "It has destroyed our most valuable resource: our people."

Called "Tshepang" or "have hope," the program is a fresh challenge to South Africa's government, which has resisted efforts to provide antiretrovirals, arguing they are dangerously toxic and prohibitively expensive.

President Thabo Mbeki has also questioned the link between HIV and AIDS--a view that has permeated discussions on the issue within the ruling African National Congress.

No senior government official attended Tuesday's launch. The Health Ministry said in a statement that while it welcomed "in principle" new treatment initiatives, it needed more information about the project before commenting on it.

South Africa has almost 5 million people infected with HIV, the virus that causes AIDS, the world's highest case load.

SAMA Chairman Kgosi Letlape said South Africa, particularly its medical community, could no longer stand by as millions died from the disease.

"Treatment of patients is our responsibility. It is time we woke up," Letlape told Reuters Wednesday. Mandela's foundation has donated 10 million rand ($1.08 million) for the project, which organizers say could cost as much as 80 million rand to get up and running.

The vast majority of the country's HIV/AIDS patients are too poor to afford antiretroviral drugs. Letlape said he knew demand would be immense. "We will be overwhelmed immediately." But organizers said the program could demonstrate to the government that it was feasible to distribute antiretrovirals.

The program will seek to negotiate cheaper drug prices from big pharmaceutical firms.

AIDS activist Zackie Achmat, who is refusing to take antiretroviral drugs for his own HIV infection until the drugs are made widely available, said the new program could push both the government and drug companies to get serious about South Africa's HIV/AIDS pandemic.


021204
RE021207


Copyright © 2002 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .